HOME >> BIOLOGY >> NEWS
Monsanto to share technologies with Danforth Center to support global cassava research

ted Nations Human Development Report 2001 also encouraged greater public investment in research and development to ensure that biotechnology is used to meet the agricultural needs of the world's poor.

"By sharing our technology and other scientific knowledge, Monsanto hopes to encourage other companies and technology developers to do the same, said Robb Fraley, Chief Technology Officer of Monsanto.

Working together in public and private sector partnerships promotes a wide variety of discoveries to enhance food security and nutrition throughout the developing world. We look forward to continuing our support of the cassava research program as it develops, said Fraley.

Monsanto also is supporting the Danforth Centers efforts to develop virus-resistant cassava through a multi-year grant from the companys philanthropic organization, the Monsanto Fund. Monsantos contributions to the Danforth Center are in keeping with the New Monsanto Pledge and its commitment to sharing knowledge and technology with public institutions to benefit people and the environment, particularly in the developing world.

In August 2000, Monsanto granted similar royalty-free licenses to the inventors of golden rice, which is being developed to combat vitamin A deficiency in developing countries. Other sharing projects include providing access to a working draft of the rice genome and participating in work to develop virus-resistant sweet potatoes in Africa and papayas in South East Asia.


'"/>

Contact: Shannon Troughton
314-694-2320
Monsanto Company
16-Apr-2002


Page: 1 2

Related biology news :

1. Washington University in St. Louis, Monsanto Co., awarded crop protection patent
2. Monsanto and researchers celebrate first anniversary of sharing rice genome sequence data
3. Monsanto adds support for golden rice; opens its rice genome sequence data to worldwide research community
4. Monsantos modified soya beans dont agree with the heat
5. Bone, enamel, dentine, milk & saliva share gene family
6. K-State researchers share $1 million grant to study insect pests
7. Cross-species comparison reveals shared features between tumorigenesis and organogenesis
8. Scientists discover that metastases share a similar genetic profile to their primary tumour
9. Drug addiction, learning share common brain protein
10. Monkey talk, human speech share left-brain processing
11. Lions share of the best of Asias progressive minds in science and medicine convene

Post Your Comments:
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... the University of Copenhagen have shown for the first ... of Cystic fibrosis patients, giving them the opportunity to ... chronic infections. , The study also discovered the bacterial ... patients was halted or slowed down by the immune ... the oxygen and helped "suffocate" the bacteria, forcing the ...
(Date:10/16/2014)... Virginia Institute of Marine Science have received a ... to identify the streams and wetlands most vulnerable ... help local governments and citizens conserve these important ... dataset of tidal-marsh observations first gathered by VIMS ... baseline can today,s researchers accurately map the slow ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3
(Date:10/25/2014)... Des Moines, Iowa (PRWEB) October 24, 2014 ... today that Perdue plans to more than double ... in 2015 in geographies supplying its soybean crush ... oil produced from this program will target several ... healthier oil alternatives with good performance. , For ...
(Date:10/25/2014)... 24, 2014 A new way to ... pitfalls of current skin grafting technologies, it also speeds ... The method, outlined in the October issue of STEM ... deep skin injuries that result from severe burns and ... the skin’s regenerative elements. These wounds heal by contraction, ...
(Date:10/25/2014)... 2014 Investor-Edge has initiated coverage ... CYTR ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ... Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM ), and ... companies can be accessed at: http://investor-edge.com/register . ... ended on a positive note as the Dow Jones ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
Breaking Biology Technology:DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 2DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 3DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 4New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
Cached News: